Serotonin (5-HT) drugs: Effects on appetite expression and use for the treatment of obesity

Current Drug Targets

Volumn 6, Issue 2, 2005, Pages 201-213

  Halford, Jason C G ^a   Harrold, Joanne A ^a   Lawton, Clare L ^b   Blundell, John E ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

5 HT; ADP356; Appetite; d fenfluramine; Food intake; mCPP; Obesity; Satiety; Serotonin; Sibutramine; Weight loss

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 5 HYDROXYTRYPTOPHAN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; 5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; ADP 356; AMPHETAMINE; DEXAMPHETAMINE; DEXFENFLURAMINE; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; MAZINDOL; MELANOCORTIN; NEUROPEPTIDE Y; OREXIN; ORG 12962; PAROXETINE; PHENTERMINE; SEROTONIN; SEROTONIN 2C AGONIST; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SERTRALINE; SIBUTRAMINE; SUMATRIPTAN; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VER 3323;

ANXIETY; APPETITE; CALORIC INTAKE; CATECHOLAMINE SYNTHESIS; CLINICAL TRIAL; DIZZINESS; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; ENERGY BALANCE; FOOD INTAKE; HUMAN; HYPERTENSION; HYPOPHAGIA; LOW CALORY DIET; META ANALYSIS; MULTIPLE DRUG DOSE; NAUSEA; NONHUMAN; NUTRITIONAL STATUS; OBESITY; REVIEW; SATIETY; SIDE EFFECT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TACHYCARDIA; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 15444368875     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450053174550     Document Type: Review

References (134)

1. Halford, J.C.G.; Blundell, J.E. (2000) Ann. Med., 32, 222-232.
2. Vickers, S.P.; Dourish, C.T. (2004) Curr. Opin. Invest. Drugs, 5, 377-388.
3. Bentley, J.M., Adams, D.R.; Bebbington, D.; Benwell, K.R.; Bickerdike, M.J.; Davidons, J.E.P.; Dawson, C.E.; Dourish, C.T.; Duncton, M.A.J.; Gaur, S.; George, A.R.; Giles, P.R.; Hamlyn, R.J.; Kennett, G.A., Knight, A.R.; Malcolm, C.S., Mansell, H.L.; Misra, A.; Monck, N.J.T.; Pratt, R.M., Quirk, K.; Roffey, J.R.A., Vickers, S.P.; Cliffe, I.A. (2004) Bioorganic Med. Chem. Let., 14, 2367-2370.
4. Bray, G.A.; York, D.A. (1972) Am. J. Physiol., 233, 176-179.
5. Jesperson, S.; Scheel-Kruger, J. (1973) J. Pharm. Pharmacol., 22, 637-638.
6. Barrett, A.M.; McSherry, L. (1975) J. Pharm. Pharmacol. 27, 889-895.
7. Pinder, B.M.; Brogden, R.N.; Sawyer, P.R.; Speight, T.M.; Avery, G.S. (1975) Drugs, 10, 241-323.
8. Garattini, S.; Samanin, R. (1976) in Food Intake and Appetite, (Silverstone, T. (ed)), Dahlem Konferenzen, Berlin, p. 82-208.
9. MacKenzie, R.G.; Hoebel, B.G.; Ducret, R.P.; Trulson, M.E. (1979) Pharmacol. Biochem. Behav., 10, 951-955.
10. Blundell, J.E. (1977) Int. J. Obesity, 1, 15-42.
11. Hoyer, D.; Martin, G. (1997) Neuropharmacology, 36, 419-428.
12. Blundell, J.E.; Halford, J.C.G. (1998) CNS Drugs, 9, 473-495.
13. Rogers, P.; McGibbons, P.E.; Williams G. (1991) Peptides, 12, 251-255.
14. Brown, C.M.; Coscina, D.V. (1995) Pharmacol. Biochem Behav, 51, 641-646.
15. Compan, V.; Dusticier, N.; Nieoullon, A.; Daszuta, A. (1996) Synapse, 24, 87-96.
16. Currie, P.J. (2003) Appetite, 41, 335-337.
17. Heisler, L.K.; Cowley, M.A.; Tecott, L.H.; Fan, W.; Low, M.J.; Smart, J.L.; Rubinstein, M.; Tatro, J.B.; Marcus, J.N.; Holstege, H.; Lee, C.E.; Cone, R.D.; Elmquist, J.K. (2002) Science, 297, 609-611.
18. Heisler, L.K., Cowley, M.A.; Kishi, T.; Tecott, L.H.; Fan, W.; Low, M.J.; Smart, J.L.; Rubinstein,.M.; Tatro, J.B.; Zigman, J.M.; Cone, R.D.; Elmquist, J.K. (2003) N.Y. Acad. Sci., 994, 169-174.
19. Nambu, T.; Sakurai, T.; Mizukami, K.; Hosoya, Y.; Yanagisawa, M.; Goto, K. (1999) Brain Res., 827, 243-260.
20. Hervieu, G.J.; Cluderay, J.E.; Harrison, D.C.; Roberts, J.C.; Leslie, R.A. (2001) Neuroscience, 103, 777-797.
21. Marcus, J.N.; Aschkenasim C.J.; Lee, C.E.; Chemelli, R.M.; Saper, C.B.; Yanagisawa, M.; Elmquist, J.K. (2001) J. Comp. Neurology, 435, 6-25.
22. Brown, R.E.; Sergeeva, O.A.; Eriksson, K.S.; Haas, H.L. (2002) J. Neuroscience, 22, 8850-8859.
23. Liu, R.J.; van den Pol, A.N.; Aghajanian, G.K. (2002) J. Neurosci., 22, 9453-9464.
24. Orlando, G.; Brunetti, L.l.; Di Nisio, C.; Michelotto, B.; Recinella, L.; Ciabattoni, G.; Vacca, M (2001) Eur. J. Pharmacol., 430, 269-272.
25. Matsuzaki, I.; Sakurai, T.; Kunii, K.; Nakamura, T.; Yanagisawa, M.; Goto, K. (2002) Reg. Peptides, 104, 119-123.
26. Brown, R.E.; Sergeeva, O.; Eriksson, K.S.; Haas, H.L. (2001) Neuropharmacology, 40, 457-459.
27. Simansky K.J. (1995) Behav. Brain Res., 73, 37-42.
28. Hewitt, K.N.; Lee, M.D., Dourish, C.T.; Clifton, P.G. (2002) Pharmacol. Biochem. Behav., 71, 691-700.
29. Collin, M.; Backberg, M.; Onnestam, K.; Meister, B. (2002) Neuroreport, 13, 945-951.
30. Muraki, Y.; Yamanaka, A.; Tsujino, N.; Kilduff, T.S.; Goto, K.; Sakurai, T. (2004) J. Neuroscience, 24, 7159-7166.
31. Barrafan-Majia, M.G.; Castilla-Serna, L.; Calderon-Guzman, D.; Hernandez-Islas, J.L.; Lbra-Ruiz N.A.; Rodrigez, A.; Angel, D.S-D, (2002) Arch. Med. Res., 33, 15-19.
32. Xie, Q.W. (1991) Neuroendocrinology, 53, 52-59.
33. Nishimura, F.; Nishihara, M.; Torii, K.; Takahashi, M. (1996) Physiol. Behav., 60, 7-12.
34. Wolfe, B.W.; Metzger, E.D.; Stollar, C. (1997) Physiol. Behav., 61, 537-541.
35. Cowen, P.J.; Clifford, E.M., Walsh A.E.S., Williams, C., Fairburn, C.G. (1996) Psychol. Med., 26, 1155-1159.
36. Varma, M.; Torelli, G.F.; Meguid, M.M.; Chai; J.K.; Blaha, V.; Laviano, A.; Kim, H.J. (1998) J. Surg. Res., 81, 69-76.
37. Yang, Z.J.; Blaha, V.; Meguid, M.M.; Laviano, A.; Oler, A.; Zadak, Z. (1999) Pharmacol. Biochem Behav., 62, 61-65.
38. Cangiano, C.; Laviano, A.; Muscaritoli, M.; Meguid, M.M.; Cascino, A.; Fanelli, F.R. (1996) Nutrition, 12, S48-S51.
39. Cangiano, C.; Testa, U.; Muscaritoli, M.; Meguid, M.M.; Mulieril, M.; Laviano, A.; Caxcino, A.; Preziosa, I.;,Conversano, L.; Fanelli, F.R. (1994) Anticancer Research, 14, 1451-1455.
40. Meguid, M.M.; Fetissov, S.O.; Blaha, V.; Yang, Z.J. (2000) Neuroreport, 11, 2069-2072.
41. Svec, F.; Thompson, H.; Porter, J. (2002) Nutr. Neurosci. 5, 321-326.
42. Harrold, J.A.; Widdowson, P.S.; Clapham, J.C.; Williams, G. (2000) Am. J. Physiol., 279, E340-E347.
43. Hassanain, M.; Levin, B.E. (2002) Brain Res., 929, 175-180.
44. Breum, L.; Rasmussen, M.H.; Hilsted, J.; Fernstorm, J.D. (2003) Am. J. Clin. Nutr., 77, 1112-1118.
45. Clifton, P.G. (1994) in Ethology and Psychopharmacology, (Cooper, S.J. (ed)), Wiley, Chichester, pp 313-328
46. Neill, J.C.; Cooper, S.J. (1989) Psychopharmacology, 97, 213-218.
47. Samanin, R.; Mennini, T.; Bendotti, C.; Barone, D.; Caccia, S.; Garattini, S. (1989) Neuropharmacology, 28, 465-469.
48. Neill, J.C.; Bendotti, C.; Samanin, R. (1990) Eur. J. Pharmacol., 190, 105-112.
49. Simansky, J.J.; Nicklous, D.M. (2002) Pharmacol. Biochem. Behav., 71, 681-690.
50. Vickers, S.P.; Dourish, C.T.; Kennett, G.A. (2001) Neuropharmacology, 41, 200-209.
51. Wong, D.T.; Reid, L.R.; Threlkeld, P.G. (1988) Pharmacol. Biochem. Behav., 31, 475-479.
52. Grignaschi, G.; Samanin, R. (1992) Neuropharmacology, 31, 445-449.
53. Lightowler, S.; Wood, M.; Brown, T.; Glen, A.; Blackburn, T.; Tulloch, I.; Kennett, G. (1996) Eur. J. Pharmacol., 296, 137-143.
54. Lee, M.D.; Clifton, P.G. (1992) Psychopharmacology, 107, 359-364.
55. Halford, J.C.G.; Blundell, J.E. (1996) Pharmacol Biochem Behav., 54, 745-751.
56. Koe, B.K.; Weissman, A. Welch, W.M.; Browne, R.G. (1983) J. Pharmacol. Exp. Ther., 266, 686-700.
57. Lucki, I.; Kreider, M.S.; Simansky, K.J. (1988) Psychopharmacology, 96, 289-295.
58. Kennett, G.A.; Curzon, G. (1988) Psychopharmacology, 96, 93-100.
59. Kennett, G.A.; Curzon, G. (1988) Br. J. Pharmacol., 94, 137-147.
60. Kennett, G.A.; Curzon, G. (1991) Br. J. Pharmacol., 10, 2016-2020.
61. Halford, J.C.G.; Blundell, J.E. (1996) Physiol. Behav., 60, 933-939.
62. Lee, M.D.; Simansky, K.J. (1997) Psychopharmacology, 131, 264-270.
63. Schreiber, R.; Selbach, K.; Asmussen, M.; Hess, D.; De Vry, J. (2000) Pharmacol. Biochem. Behav., 67, 291-305.
64. Clifton, P.G.; Lee, M.D.; Dourish, C.T. (2000) Psychopharmacology, 152, 256-267.
65. Lee, M.D.; Kennett, G.A.; Dourish, C.T.; Clifton, P.G. (2002) Psychopharmacology, 164, 49-60.
66. Blundell, J.E.; Latham, C.J. (1978) in Central Mechanisms of Anorectic Drugs, (Garattini, S., Samanin, R. (eds)), Raven Press, NY. 83-109.
67. Halford, J.C.G.; Wanninayake, S.C.D.; Blundell, J.E. (1998) Pharmacol. Biochem. Behav., 61, 159-168.
68. Blundell, J.E.; Latham, C.J. (1980) Pharmacol. Biochem. Behav., 12, 717-722.
69. Blundell, J.E.; McArthur, R.A. (1981) in Anorectic Agents: Mechanisms of Action and Tolerance, (Samanin, R., Garattini, S. (eds)), Raven, NY. pp 19-43
70. Halford, J.C.G.; Blundell, J.E. (1993) Br. J. Pharmacol., 100, 95.
71. Clifton, P.G.; Barnfield, A.M.C.; Philcox, L. (1989) Psychopharmacology, 97, 89-95.
72. Simansky, K.J.; Viadya, A.H. (1990) Brain. Res. Bull., 25, 953-960.
73. McGuirk, J.; Muscat, R.; Willner, P. (1992) Pharmacol. Biochem. Behav., 4, 801-805.
74. Kitchener, S.J.; Dourish, C.T. (1994) Psychopharmacology 113, 368-377.
75. Tecott, L.H.; Sun, L.M.; Akanna, S.F.; Strack, A.M.; Lowenstein, D.H.; Dallman, M.F.; Julis, D. (1995) Nature, 374, 542-546.
76. Nonogaki. K.; Abdullah, L.; Goulding E.H.; Bonasera, S.J.; Tecott, L.H. (2003) Diabetes, 52, 315-320.
77. Vickers, S.P.; Clifton, P.G.; Dourish, C.T.; Tecott, L.H. (1999) Psychopharmacology, 143, 309-314.
78. Bouwknecht, J.A.; van der Guten, J.; Hijsenm, T.H.; Maes, R.A.A.; Hen, R. Olivier, B. (2001) Physiol. Behav., 74, 507-516.
79. Cangiano, C.; Ceci, F.; Casinco, A.; Del Ben, M.; Laviano, A.; Mauscatioli, M.; Antonucci, F.; Rossi-Fanelli, F. (1992) Am. J. Clin. Nutr., 56, 863-867.
80. Cangiano, C.; Laviano, A.; Del Ben, M.; Preziosa, I.; Angelico, F.; Casinco, A.; Rossi-Fanelli, F. (1988) Int. J. Obesity, 22, 648-654.
81. Rogers, P.J.; Blundell, J.E. (1979) Psychopharmacology, 66, 159-165.
82. Foltin, R.W.;Haney, M.; Comer, S.; Fischman, M.W. (1996a) Physiol. Behav., 59, 295-305
83. Goodall, E.; Silverstone, T. (1988) Appetite, 11, 215-288.
84. Blundell, J.E.; Hill, A.J. (1990) Int. J. Obesity, 14, 121-134.
85. Drent, M.L.; Zelissen, P.M.J.; Kopperchaar, H.P.F.; Krusemans, A.C.N.; Lutterman, J.A.; van der Veen, E.A. (1995) Int. J. Obesity, 19, 299-304.
86. McGuirk, J.; Silverstone, T. (1990) Int. J. Obesity, 14, 361-372.
87. Pijl, H.; Koppeschaar, H.P.F.; Willekens, F.L.A.; de Kamp, I.O.; Veldhuis, H.D.; Meinder, A.E. (1991) Int. J. Obesity, 15, 237-242.
88. Lawton, C.L.; Wales, J.K.; Hill, A.J.; Blundell, J.E. (1995) Obesity. Res., 3, 345-356.
89. Ward, A.S.; Comer, S.D.; Haney, M.; Fischman, M.W.; Foltin, R.W. (1999) Physiol. Behav., 66, 815-821.
90. Chapelot, D.; Mamonier, C.; Thomas, F.; Hanotin, C. (2000) Physiol Behav., 68, 299-308.
91. Hansen, D.L.; Toubro, S.; Stock, M.J.; Macdonald, I.A.; Astrup, A. (1998) Am. J. Clin. Nutr., 86, 1180-1186.
92. Rolls, B.J.; Shide, D.J.;Thorward, M.L.; Ulbrecht, J.S. (1998) Obesity Res., 6, 1-11.
93. Hansen, D.L.; Toubro, S.; Stock, M.J.; Macdonald, I.A.; Astrap, A. (1999) Int. J. Obesity, 23, 1016-1024.
94. Barkeling, B.; Elfhag, K.; Rooth, P.; Rossner, S. (2003) Int. J. Obesity, 27, 693-700.
95. Walsh, A.E.; Smith, K.A.; Oldman, A.D. (1994) Psychopharmacology, 116, 120-122.
96. Cowen, P.J.; Sargent, P.A.; Williams, C.; Goodall, E.M.; Olikov, A.B. (1995) Human Psychopharmacology, 10, 385-391
97. Sargent, P.A.; Sharpley, A.L.; Williams, C.; Goodall, E.M.; Cowen, P.J. (1997) Psychopharmacology, 133, 309-312.
98. Ghaziuddin, N.; Welch, K.; Greden, J. (2003) Neuropsychopharmacology, 28, 133-139.
99. Boeles, S.; Williams, C.; Campling, G.M.; Goodall, E.M.; Cowen, P.J. (1997) Psychopharmacology, 129(2), 179-182.
100. Fisler, J.S.; Undernerger, S.J.; York, D.A.; Bray, G.A. (1993) Pharmacol. Biochem. Behav., 45, 487-493.
101. Vickers, S.P.; Benwell, K.R.; Porter, R.H.; Bickerdike, M.J.; Kennett, G.A., Dourish, C.T. (2000) Br. J. Pharmacol., 130, 1305-1314.
102. Vickers, S.P.; Easton, N.; Webster, L.J.; Wyatt, A.; Birkerdike, M.J.; Dourish, C.T.; Kennett, G.A. (2003) Psychopharmacology, 167, 274-280.
103. Yen, T.T.; Wong, D.T.; Bemis, K.G. (1987) Drug Dev. Res. 10, 37-47.
104. Fuller, R.W.; Wong, D.T. (1989) Drug Dev. Res., 17, 1-15.
105. Nielsen, J.A., Chapin, D.S.; Johson, J.L.; Torgersen, L.K. (1992) Am. J. Clin. Nutr., 55, 185s-188s.
106. Wieczorek, I.; Schulz, C.; Jarry, H.; Lehnert, H. (2001) Int. J. Obesity, 25, 1566-69.
107. Konkle, A.T.M.; Sreter, K.B.; Bajer, S.L.; Bielajew, C. (2003) Pharmacol Biochem. Behav., 74, 883-890.
108. Kennett, G.A.; Wood, M.D.; Bright, F.; Trail, B.; Riley, G.; Holland, V.; Avenel, K.Y.; Stean, T.; Upton. N.; Bromidge, S.; Forbes, I.T.; Brown, A.M., Middledmiss, D.N.; Blackburn, T.P. (1997) Neuropharmacology, 36, 609-620.
109. Hayashi, A.; Sonoda, R.; Kimura, Y.; Suzuki, M.; Sasamata, M.; Miyate, K. (2004) Brain Res., 1011, 221-227.
110. Bjenning, C.; Willaims, J.; Whelan, K.; Gonzalez, L.; Creehan, K.; Smith, B.; Webb, R.; Thomsen, B.; Reyes H.; Espista, S.; Sengupta, D.; Chen, R.; Estrade, A.; Bagnol, D.; Howey, J.; Martin, M.; Agarwal, R.; Henshilwood, J.; Maffuid, P.; Prosser, W.; Beeley, N.; Shanahan, W.; Behan, S.; Chalmers, D. (2004) Int. J. Obesity, 28 (suppl. 1), s214.
111. Haddock, C.K.; Poston, W.S.C.; Dill, P.L.; Froreyt J.P.; Ericsson, M. (2002) Int. J. Obesity, 26, 262-273.
112. Pinder, R.M.; Brogden, R.N.; Sawyer, P.R. Speight, T.M., Avery, G.S. (1975) Drugs, 10, 241-323.
113. Guy-Grand, B.; Apfelbaum, M.; Creoaldi, C.; Gries, A.; Lefebevre, P.; Turner, P (1989) Lancet 2, 1142-1145.
114. Guy-Grand, B. (1992) Am J. Clin. Nutr., 55, 173-176s.
115. Finer, N.; Finer, S.; Naoumova, R.P. (1992) Am. J. Clin. Nutr., 56, 195-198s.
116. James, W.P.T.; Astrup, A.; Finer, N.; Hiltes, J.; Kopleman, P.; Rössner, S.; Saris, W.H.M.; Van Gaal, L.F. (2000) Lancet, 356, 2119-25.
117. McMohan, F.G.; Fujioja, K.; Singh, B.N.; Mendel, C.M.; Rowe, R.; Rolston, K; Johnson F.; Morradian, A.D. (2000) Arch. Intern. Med., 160, 2185-91.
118. Smith, I.G.; Goulder, M.A. (2001) J. Fam. Pract., 50, 505-12
119. McNulty S.J.; Ur, E.; Williams. G. (2003) Diabetes Care, 26, 125-33.
120. Poston, W.S.C.; Reeves, R.S.; Haddock, C.K.; Stormer, S.; Balasubramanyam, A.; Satterwhite, O.; Taylor, J.E.; Foreyt, J.P. (2003) Int. J. Obesity, 27, 1486-93.
121. Arterburn, D.E.; Crane, P.K.; Veenstra, D.L. (2004) Arch. Intern. Med., 164, 994-1003.
122. Padwal, R.; Li, S.K.; Lau, D.C.W. (2003) Int. J. Obesity, 27, 1437-46.
123. Wise, S.D. (1992) Am. J. Clin. Nutr., 55, 181-184s.
124. Goldstein, D.J.; Rampey, A.H.; Roback, P.J.; Wilson, M.G.; Hamilton, S.H.; Sayler, M.E.; Tollefson, G.D. (1994) Obesity Res., 3, 481-490s.
125. Darga, L.L.; Carroll-michals, C.; Botsford, S.J.; Lucas, P.C. (1991) Am. J. Clin. Nutr., 54, 321-315.
126. Goldstein, D.J.; Rampey, A.H.; Enas, G.G.; Potvin, J.H.; Fludzinski, L.A.; Levine, L.R. (1994) Int. J. Obesity, 18, 129-135.
127. Wadden, T.A.; Bartlet, S.J.; Foster, G.D.; Greenstein, R.A.; Wingate, B.J.; Stunkard, A.J.; Letizia, K.A. (1995) Obesity Res., 3, 549-557.
128. Simpson, R.J.; Lawton, D.J.; Watt, M.H.; Tipley, B. (1981) Br. J. Clin. Pharmac., 11, 96-98.
129. Van Baak, M.; Lentjes, M.; Mujakovic, S.; Slaap, B.; Saris, W. (2003) Obesity Res., 11 (suppl. 1), A111.
130. Abeniam, L.; Moride, Y.; Brenot, F.; Rich, S.; Benichou, J.; Kruz, X.; Higenbottam, T.; Oakley, C.; Wouters, E.; Audier, M.; Simonneau, G., Begaud, B. (1996) N. Engl. J. Med., 335, 609-616.
131. Bays, H.E. (2004) Obesity Res., 12, 1197-1211.
132. www.arenapharma.com (accessed 22nd December 2004).
133. Halford, J.C.G.; Cooper, G.D.; Dovey, T.M.; Ishii, Y.; Rodgers, R.J.; Blundell, J.C.G. (2003) Curr. Med. Chem. Cent. Nerv. Syst. Agents, 3, 283-310.
134. Halford, J.C.G. (2004) Curr. Drug Targets, 5, 637-46.